These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 38111626)

  • 1. Expert group recommendation on inhaled mucoactive drugs in pediatric respiratory diseases: an Indian perspective.
    Singh M; Varkki S; Kinimi I; Das RR; Goyal JP; Bhat M; Dayal R; Kalyan P; Gairolla J; Khosla I
    Front Pediatr; 2023; 11():1322360. PubMed ID: 38111626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
    Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE
    Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled mannitol for cystic fibrosis.
    Nevitt SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2020 May; 5(5):CD008649. PubMed ID: 32358807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled mannitol for cystic fibrosis.
    Nevitt SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008649. PubMed ID: 29424930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational use of mucoactive medications to treat pediatric airway disease.
    Linssen RSN; Ma J; Bem RA; Rubin BK
    Paediatr Respir Rev; 2020 Nov; 36():8-14. PubMed ID: 32653467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of mucoactive agents in cystic fibrosis: A consensus survey of Italian specialists.
    Volpi S; Carnovale V; Colombo C; Raia V; Blasi F; Pappagallo G;
    Health Sci Rep; 2022 Jul; 5(4):e604. PubMed ID: 35677472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled mannitol for cystic fibrosis.
    Nolan SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008649. PubMed ID: 26451533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.
    Snijders D; Calgaro S; Bertozzi I; Quartesan S; Kozuh I; Lunardi F; Barbato A
    Int J Immunopathol Pharmacol; 2013; 26(2):529-34. PubMed ID: 23755770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic agents for mucus clearance in bronchiectasis.
    Nair GB; Ilowite JS
    Clin Chest Med; 2012 Jun; 33(2):363-70. PubMed ID: 22640851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucoactive agents for adults with acute lung conditions: A systematic review.
    Tarrant BJ; Maitre CL; Romero L; Steward R; Button BM; Thompson BR; Holland AE
    Heart Lung; 2019; 48(2):141-147. PubMed ID: 30409442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance].
    Miyata T
    Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucoactive drugs and multiple applications in pulmonary disease therapy.
    Hocquigny A; Hugerot H; Ghanem R; Haute T; Laurent V; Cogulet V; Montier T
    Eur J Pharm Biopharm; 2024 Jan; 194():110-117. PubMed ID: 38048888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucoactive drugs.
    Balsamo R; Lanata L; Egan CG
    Eur Respir Rev; 2010 Jun; 19(116):127-33. PubMed ID: 20956181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucoactive agents for acute respiratory failure in the critically ill: a systematic review and meta-analysis.
    Anand R; McAuley DF; Blackwood B; Yap C; ONeill B; Connolly B; Borthwick M; Shyamsundar M; Warburton J; Meenen DV; Paulus F; Schultz MJ; Dark P; Bradley JM
    Thorax; 2020 Aug; 75(8):623-631. PubMed ID: 32513777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of mucoactive agents in the mechanically ventilated patient: a review of the literature.
    Icard BL; Rubio E
    Expert Rev Respir Med; 2017 Oct; 11(10):807-814. PubMed ID: 28737047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?
    Bilton D; Stanford G
    Curr Opin Pulm Med; 2014 Nov; 20(6):601-6. PubMed ID: 25221855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway clearance, mucoactive therapies and pulmonary rehabilitation in bronchiectasis.
    O'Neill K; O'Donnell AE; Bradley JM
    Respirology; 2019 Mar; 24(3):227-237. PubMed ID: 30650472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dornase alfa for cystic fibrosis.
    Yang C; Montgomery M
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001127. PubMed ID: 33735508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.